Aim: To analyze the association between Primary Health Care (PHC) performance and institutional ability to provide care for individuals with noncommunicable diseases (NCDs).
Methods: Cross-sectional study conducted with primary care nurses and physicians in Brazil. The performance of PHC was assessed by using the Primary Care Assessment Tool (PCAT), whereas institutional ability for the care of people with NCDs was assessed through the Assessment of Chronic Illness Care (ACIC). Pearson correlation and multiple linear regression models were used to analyze the association between the PHC attributes measured in the PCAT (independent variables) and the ACIC dimensions (dependent variables).
Results: In total, 308 health professionals -190 nurses (61.7%) and 118 physicians (38.3%)-at mean age 37.5 years and mean time of 6.5 years working in PHC participated of the study. On a scale of 0 to 10, the overall PCAT score was 6.74, while the ACIC score was 5.20. The PCAT score was High in only 58.8% of respondents (score ≥6.6). The ACIC scores showed basic institutional ability to care for people with NCDs. All ACIC dimensions have shown positive correlation to PCAT attributes, except for accessibility, continuity of care and care coordination.
Conclusion: A positive association was found between PHC performance and institutional ability to care for people with NCDs. Results have evidenced the need of investing in PCH by providing technical, political, logistical and financial support to PHC units to improve PHC organization points and care for people with NCDs.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11572130 | PMC |
| http://dx.doi.org/10.3389/fmed.2024.1374801 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Transitioning From Nusinersen to Risdiplam for Spinal Muscular Atrophy in Clinical Practice: A Single-Center Experience.
Muscle Nerve
January 2025
Center for Gene Therapy, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, Ohio, USA.
Background: Nusinersen and risdiplam are U.S. Food and Drug Administration (FDA)-approved treatments for spinal muscular atrophy (SMA).
View Article and Find Full Text PDF6-Indolo-[2,3-]-quinoxaline derivatives as promising bifunctional SHP1 inhibitors.
Org Biomol Chem
January 2025
School of Life Sciences and Health Engineering, Jiangnan University, Jiangsu, 214122, China.
Dysfunction in the SHP1 enzyme can cause cancers and many diseases, so it is of great significance to develop novel small molecule SHP1 inhibitors. Through continuous monitoring of metabolic and targeted processes of SHP1 inhibitors in real-time, we can evaluate the effectiveness and toxicity of the inhibitors, further optimize drug design, and explore SHP1 biology. Indoloquinoxaline is an important class of N-containing heterocycle, which has been studied and applied in the pharmacological field and in optoelectronic materials.
View Article and Find Full Text PDFMechanism of oxygen reduction chemical affinity in NiO/SiO interfaces irradiated with keV energy hydrogen and helium ions for heterostructure fabrication.
Nanoscale Horiz
January 2025
Departmento de Fisica, Universidad Técnica Federico Santa María, Av. España 1680, Valparaíso, Chile.
Low-energy light ion beams are an essential resource in lithography for nanopatterning magnetic materials and interfaces due to their ability to modify the structure and properties of metamaterials. Here we create ferromagnetic/non-ferromagnetic heterostructures with a controlled layer thickness and nanometer-scale precision. For this, hydrogen ion (H) irradiation is used to reduce the antiferromagnetic nickel oxide (NiO) layer into ferromagnetic Ni with lower fluence than in the case of helium ion (He) irradiation.
View Article and Find Full Text PDFStrategies to Enhance the Therapeutic Efficacy of GLP-1 Receptor Agonists through Structural Modification and Carrier Delivery.
Chembiochem
January 2025
Nankai University, Institute of Polymer Chemistry, CHINA.
Diabetes is a metabolic disorder characterized by insufficient endogenous insulin production or impaired sensitivity to insulin. In recent years, a class of incretin-based hypoglycemic drugs, glucagon-like peptide-1 receptor agonists (GLP-1RAs), have attracted great attention in the management of type 2 diabetes mellitus (T2DM) due to their benefits, including stable glycemic control ability, a low risk of hypoglycemia, and weight reduction for patients. However, like other peptide drugs, GLP-1RAs face challenges such as instability, susceptibility to enzymatic degradation, and immunogenicity, which severely limit their clinical application.
View Article and Find Full Text PDFMachine Learning Predictions of Recovery in Bilingual Poststroke Aphasia: Aligning Insights With Clinical Evidence.
Stroke
January 2025
Center for Brain Recovery, Boston University, MA (M.J.M., E.C., M.S., M.R.-M., S.K.).
Background: Predicting treated language improvement (TLI) and transfer to the untreated language (cross-language generalization, CLG) after speech-language therapy in bilingual individuals with poststroke aphasia is crucial for personalized treatment planning. This study evaluated machine learning models to predict TLI and CLG and identified the key predictive features (eg, patient severity, demographics, and treatment variables) aligning with clinical evidence.
Methods: Forty-eight Spanish-English bilingual individuals with poststroke aphasia received 20 sessions of semantic feature-based naming treatment in either their first or second language.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!